This clinical trial tested the use of the TENA SmartCare Change Indicator in a homecare environment.
The trial included 35 elderly subjects with urinary incontinence. The trial lasted for 3 weeks. The primary outcome was the reduction in manual absorbing product checks between the baseline (first) and the investigational (third) week.
The numbers of checks and leakages were significantly reduced by 16% (p = 0.001) and 40% (p = 0.0051).
Use of the device led to a reduction in the numbers of manual checks and leakages. The device appears to be safe, well tolerated and easy to use.
Archives of medical science : AMS. 2023 Jan 13*** epublish ***
Fredrik Agholme, Artur Lamparski, Piotr Radziszewski
Essity Hygiene and Health AB, Sweden., Medical Concierge, Poland., Department of Urology, Warsaw Medical University, Poland.